Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
422 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Condition: Ovarian Neoplasms
Interventions: Procedure: Pelvic imaging;   Procedure: Blood draw;   Procedure: laparotomy or laparoscopy
2 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
3 Recruiting Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
Condition: Ovarian Neoplasms
Intervention: Procedure: Abnormal Ovarian Ultrasound
4 Recruiting The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
Condition: Ovarian Neoplasms
Intervention: Other: Observational cohort
5 Recruiting Phase II/III Trial of Maintenance Vigil™ for High Risk Stage III/IV Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Biological: Vigil;   Biological: Placebo
6 Recruiting Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Regorafenib
7 Recruiting Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Condition: Ovarian Cancer
Intervention: Drug: pazopanib in combination with weekly topotecan
8 Recruiting EC17 for Intraoperative Imaging in Occult Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: EC17
9 Recruiting Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Drug: 18F-EF5 PET/CT scan;   Procedure: Optional biopsy
10 Not yet recruiting Improving Quality of Care for Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Neoplasms;   Quality of Life
Intervention: Other: Questionnaires
11 Recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
12 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
13 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
14 Not yet recruiting Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
Condition: Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Laparotomy
15 Recruiting Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Condition: Ovarian Cancer
Intervention:
16 Recruiting Sentinel Node Detection in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Sentinel Node
Intervention: Procedure: Injection of radioactive tracer combined with Patent Blue
17 Not yet recruiting Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Condition: Recurrent Platinum Resistant Ovarian Cancer
Intervention: Drug: cediranib and olaparib
18 Recruiting Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Apatinib;   Drug: Etoposide
19 Recruiting Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm
Condition: Stage IIIC Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Cytoreduction
20 Recruiting Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer
Condition: Metastatic Ovarian Cancer
Intervention: Other: Experimental arm

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.